Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David G Denardo

Showing results (51-60 of 101) with videos related to

Pageof 11
Sort By:
Gastroenterology|March 10, 2022
IRAK4 Signaling Drives Resistance to Checkpoint Immunotherapy in Pancreatic Ductal AdenocarcinomaVikas K Somani, Daoxiang Zhang, Paarth B Dodhiawala, et al.
Nature Medicine|July 5, 2016
Targeting focal adhesion kinase renders pancreatic cancers responsive to checkpoint immunotherapyHong Jiang, Samarth Hegde, Brett L Knolhoff, et al.
Oncotarget|August 16, 2019
Precision delivery of RAS-inhibiting siRNA to KRAS driven cancer via peptide-based nanoparticlesMatthew S Strand, Bradley A Krasnick, Hua Pan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 1, 2021
Neoadjuvant FOLFIRINOX Therapy Is Associated with Increased Effector T Cells and Reduced Suppressor Cells in Patients with Pancreatic CancerHui Peng, C Alston James, Darren R Cullinan, et al.
Cancer Cell|November 22, 2024
Interleukin-1α release during necrotic-like cell death generates myeloid-driven immunosuppression that restricts anti-tumor immunityKay Hänggi, Jie Li, Achintyan Gangadharan, et al.
Oncotarget|June 1, 2016
Conjugation to the sigma-2 ligand SV119 overcomes uptake blockade and converts dm-Erastin into a potent pancreatic cancer therapeuticKerri A Ohman, Yassar M Hashim, Suwanna Vangveravong, et al.
Nature Communications|June 9, 2016
Stromal senescence establishes an immunosuppressive microenvironment that drives tumorigenesisMegan K Ruhland, Andrew J Loza, Aude-Helene Capietto, et al.
Cancer Discovery|November 1, 2011
Leukocyte complexity predicts breast cancer survival and functionally regulates response to chemotherapyDavid G DeNardo, Donal J Brennan, Elton Rexhepaj, et al.
JCI Insight|December 16, 2021
Stromal architecture directs early dissemination in pancreatic ductal adenocarcinomaArja Ray, Mackenzie K Callaway, Nelson J Rodríguez-Merced, et al.
ACS Pharmacology & Translational Science|January 17, 2024
Chemokine Receptor 2 Targeted PET/CT Imaging Distant Metastases in Pancreatic Ductal AdenocarcinomaXiaohui Zhang, Lisa Detering, Gyu Seong Heo, et al.
Pageof 11

Showing results (51-60 of 101) with videos related to

Sort By:
Pageof 11
Gastroenterology|March 10, 2022
IRAK4 Signaling Drives Resistance to Checkpoint Immunotherapy in Pancreatic Ductal AdenocarcinomaVikas K Somani, Daoxiang Zhang, Paarth B Dodhiawala, et al.
Nature Medicine|July 5, 2016
Targeting focal adhesion kinase renders pancreatic cancers responsive to checkpoint immunotherapyHong Jiang, Samarth Hegde, Brett L Knolhoff, et al.
Oncotarget|August 16, 2019
Precision delivery of RAS-inhibiting siRNA to KRAS driven cancer via peptide-based nanoparticlesMatthew S Strand, Bradley A Krasnick, Hua Pan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 1, 2021
Neoadjuvant FOLFIRINOX Therapy Is Associated with Increased Effector T Cells and Reduced Suppressor Cells in Patients with Pancreatic CancerHui Peng, C Alston James, Darren R Cullinan, et al.
Cancer Cell|November 22, 2024
Interleukin-1α release during necrotic-like cell death generates myeloid-driven immunosuppression that restricts anti-tumor immunityKay Hänggi, Jie Li, Achintyan Gangadharan, et al.
Oncotarget|June 1, 2016
Conjugation to the sigma-2 ligand SV119 overcomes uptake blockade and converts dm-Erastin into a potent pancreatic cancer therapeuticKerri A Ohman, Yassar M Hashim, Suwanna Vangveravong, et al.
Nature Communications|June 9, 2016
Stromal senescence establishes an immunosuppressive microenvironment that drives tumorigenesisMegan K Ruhland, Andrew J Loza, Aude-Helene Capietto, et al.
Cancer Discovery|November 1, 2011
Leukocyte complexity predicts breast cancer survival and functionally regulates response to chemotherapyDavid G DeNardo, Donal J Brennan, Elton Rexhepaj, et al.
JCI Insight|December 16, 2021
Stromal architecture directs early dissemination in pancreatic ductal adenocarcinomaArja Ray, Mackenzie K Callaway, Nelson J Rodríguez-Merced, et al.
ACS Pharmacology & Translational Science|January 17, 2024
Chemokine Receptor 2 Targeted PET/CT Imaging Distant Metastases in Pancreatic Ductal AdenocarcinomaXiaohui Zhang, Lisa Detering, Gyu Seong Heo, et al.
Pageof 11